Page 20 - GTM-4-1

Global Translational Medicine Advancements in cardiac regenerative therapy

doi: 10.1016/j.stem.2024.08.008 49. Thomas D, Cunningham NJ, Shenoy S, Wu JC. Human-
induced pluripotent stem cells in cardiovascular research:
39. Kim JJ, Yang L, Lin B, et al. Mechanism of automaticity in
cardiomyocytes derived from human induced pluripotent current approaches in cardiac differentiation, maturation
strategies, and scalable production. Cardiovasc Res.
stem cells. J Mol Cell Cardiol. 2015;81:81-93.
2021;118(1):20-36.
doi: 10.1016/j.yjmcc.2015.01.013
doi: 10.1093/cvr/cvab115
40. Gonzalez DM, Dariolli R, Moyett J, et al. Transient
notch activation converts pluripotent stem cell-derived 50. Kamakura T, Makiyama T, Sasaki K, et al. Ultrastructural
cardiomyocytes towards a purkinje fiber fate. bioRxiv maturation of human-induced pluripotent stem cell-
[Preprint]. 2024. derived cardiomyocytes in a long-term culture. Circ J.
2013;77(5):1307-1314.
doi: 10.1101/2024.09.22.614353
doi: 10.1253/circj.cj-12-0987
41. Loh KM, Ang LT. Building human artery and vein 51. Satsuka A, Ribeiro AJS, Kawagishi H, et al. Contractility
endothelial cells from pluripotent stem cells, and enduring assessment using aligned human iPSC-derived
mysteries surrounding arteriovenous development. Semin cardiomyocytes. J Pharmacol Toxicol Methods.
Cell Dev Biol. 2023;155:62-75.
2024;128:107530.
doi: 10.1016/j.semcdb.2023.06.004
doi: 10.1016/j.vascn.2024.107530
42. Salameh S, Ogueri V, Posnack NG. Adapting to a new
environment: Postnatal maturation of the human 52. Hamledari H, Asghari P, Jayousi F, et al. Using human
cardiomyocyte. J Physiol. 2023;601(13):2593-2619. induced pluripotent stem cell-derived cardiomyocytes
to understand the mechanisms driving cardiomyocyte
doi: 10.1113/jp283792 maturation. Front Cardiovasc Med. 2022;9:967659.
43. Prondzynski M, Berkson P, Trembley MA, et al. Efficient doi: 10.3389/fcvm.2022.967659
and reproducible generation of human iPSC-derived 53. Yoshida A, Sekine W, Homma J, et al. Development of
cardiomyocytes and cardiac organoids in stirred suspension appropriate fatty acid formulations to raise the contractility of
systems. Nat Commun. 2024;15(1):5929.
constructed myocardial tissues. Regen Ther. 2022;21:413-423.
doi: 10.1038/s41467-024-50224-0
doi: 10.1016/j.reth.2022.09.006
44. Rapöhn M, Cyganek L, Voigt N, Hasenfuß G, Lehnart SE,
Wegener JW. Noninvasive analysis of contractility during 54. Young KM, Reinhart-King CA. Cellular mechanosignaling
identical maturations revealed two phenotypes in ventricular for sensing and transducing matrix rigidity. Curr Opin Cell
but not in atrial iPSC-CM. Am J Physiol Heart Circ Physiol. Biol. 2023;83:102208.
2024;326(3):H599-H611. doi: 10.1016/j.ceb.2023.102208
doi: 10.1152/ajpheart.00527.2023 55. Dai Y, Mu J, Zhou F. The use of electrical stimulation
to induce cardiac differentiation of stem cells for the
45. Lu A, Gu R, Chu C, et al. Inhibition of Wnt/β‐catenin signaling treatment of myocardial infarction. Rev Cardiovasc Med.
upregulates Nav1.5 channels in Brugada syndrome iPSC‐ 2021;22(4):1167-1171.
derived cardiomyocytes. Physiol Rep. 2023;11(10):e15696.
doi: 10.31083/j.rcm2204125
doi: 10.14814/phy2.15696
56. Sandora N, Putra MA, Busro PW, et al. Preparation of cell-
46. Sánchez-Duffhues G, Hiepen C. Human IPSCs as
model systems for BMP-related rare diseases. Cells. seeded heart patch in vitro; Co-culture of adipose-derived
mesenchymal stem cell and cardiomyocytes in amnion
2023;12(17):2200.
bilayer patch. Cardiovasc Eng Technol. 2021;13(2):193-206.
doi: 10.3390/cells12172200
doi: 10.1007/s13239-021-00565-4
47. Røsand Ø, Wang J, Scrimgeour N, Marwarha G, Høydal MA. 57. Vivas A, IJspeert C, Pan JY, et al. Generation and culture
Exosomal preconditioning of human IPSC-Derived of cardiac microtissues in a microfluidic chip with a
cardiomyocytes beneficially alters cardiac electrophysiology reversible open top enables electrical pacing, dynamic drug
and micro RNA expression. Int J Mol Sci. 2024;25(15):8460.
dosing and endothelial cell co‐culture. Adv Mater Technol.
doi: 10.3390/ijms25158460 2022;7(7):2101355.
48. Martyniak A, Jeż M, Dulak J, Stępniewski J. Adaptation doi: 10.1002/admt.202101355
of cardiomyogenesis to the generation and maturation of 58. Rupert C, López JE, Cortez-Toledo E, et al. Increased length-
cardiomyocytes from human pluripotent stem cells. IUBMB dependent activation of human engineered heart tissue
Life. 2022;75(1):8-29.
after chronic α1A-adrenergic agonist treatment: Testing a
doi: 10.1002/iub.2685 novel heart failure therapy. Am J Physiol Heart Circ Physiol.

Volume 4 Issue 1 (2025) 12 doi: 10.36922/gtm.5745